(888) 508-6752

GalaFLEX Breast Mesh Lawsuit [2026 Update]

4.9
Google
•
705 reviews

Legal Investigation: Injuries and Complications Potentially Linked to Internal Bra Mesh Products

TorHoerman Law is reviewing potential GalaFLEX breast mesh lawsuit claims involving patients who received a GalaFLEX scaffold during a breast procedure and later experienced complications requiring additional medical care.

GalaFLEX is a bioresorbable synthetic material designed to provide temporary soft tissue support during healing.

Infection, fluid buildup, wound complications, pain, and the need for additional surgery can occur following breast procedures, with or without mesh, and do not by themselves establish that GalaFLEX caused an injury.

Our attorneys evaluate the product used, operative records, medical findings, and corrective treatment to determine whether a patient’s circumstances warrant further investigation.

GalaFLEX Breast Mesh Lawsuit

GalaFLEX Scaffolds, Breast Surgery, and Potential Legal Claims

GalaFLEX is a poly-4-hydroxybutyrate (P4HB) surgical scaffold in the Becton, Dickinson and Company (BD) product portfolio.

The scaffold is designed to provide structural support where soft tissue is weakened, including in plastic surgery and reconstructive surgery.

Plastic surgeons have used GalaFLEX in certain aesthetic breast surgery and reconstructive procedures, sometimes as part of an “internal bra” technique to reinforce tissue or help maintain breast or implant position.

In a November 9, 2023, letter to health care providers, the U.S. Food and Drug Administration (FDA) identified GalaFLEX products as cleared for soft tissue repair and reinforcement, while stating that it had not determined the safety and effectiveness of surgical mesh for breast augmentation or reconstruction.

The FDA’s communication addressed labeling that BD had already updated, including warnings and precautions; it did not announce that BD was under enforcement investigation or that GalaFLEX had been found defective.

Published studies have reported favorable results with GalaFLEX and other P4HB scaffolds in several breast procedures. The findings depend on the procedures and patient groups studied, and the evidence includes studies with limited sample sizes or comparison groups.

Complications after a breast procedure may reflect patient health, tissue quality, prior treatment, surgical technique, implant-related factors, or other causes.

Our firm reviews potential claims individually, including whether medical and product-specific evidence supports further investigation of an alleged injury.

If you underwent breast surgery involving GalaFLEX and later required substantial medical treatment or corrective surgery, contact TorHoerman Law for a free consultation.

You can also use the chat feature on this page to discuss your surgical history with our team.

GalaFLEX Breast Mesh Lawsuit

What Is GalaFLEX?

GalaFLEX is a synthetic, bioresorbable surgical scaffold made from P4HB, a polymer intended to provide temporary reinforcement while the surrounding breast tissue heals and remodels.

The GalaFLEX family includes GalaFLEX, GalaFLEX LITE, GalaFLEX 3D, and GalaFLEX 3DR scaffolds, although their designs and specific labeling differ.

BD describes the devices as products for general soft tissue reinforcement and related soft tissue repair applications where weakened tissue requires additional support.

In its U.S. patient brochure, BD describes GalaFLEX as a material intended to support tissue as new collagen develops, with gradual breakdown over approximately 18 to 24 months.

That is the manufacturer’s described absorption process, not a guarantee of an identical course in every patient.

The P4HB scaffold is intended for tissue reinforcement, not to create breast volume, replace breast tissue removed during mastectomy, or function as a breast implant.

Its intended role is to reinforce the patient’s own tissue and help maintain structural integrity during the early healing period.

How GalaFLEX Is Used in Breast Surgery and Internal Bra Procedures

In internal bra surgery, a surgeon may position a scaffold beneath or alongside breast tissue and secure it with sutures to help provide structural support during healing.

The positioning depends on the procedure, implant location, available tissue, and the surgeon’s clinical judgment.

For example, a scaffold may be used near the inframammary fold, or breast fold, to support the lower part of the breast or help maintain an implant pocket.

Surgeons may also consider reinforcement in a ptotic breast, meaning a breast affected by drooping, or when excess skin and weakened tissue make long-term support a surgical consideration.

Patients with sagging breasts following pregnancy, aging, significant weight loss, or massive weight loss may undergo a breast lift or breast reduction, but the use of a mesh scaffold is not necessary in every procedure.

GalaFLEX has also been described in some implant-based reconstruction techniques, including selected cases of prepectoral breast reconstruction, where an implant is positioned in front of the pectoral muscle.

Breast surgery applications described in clinical literature include:

  • Breast lift surgery (mastopexy) to provide additional support after reshaping the breast
  • Breast reduction procedures where tissue reinforcement is considered useful
  • Implant augmentation or revision to reinforce selected portions of the implant pocket
  • Reconstructive breast procedures following mastectomy, including certain implant-based approaches
  • Revision surgery addressing implant position, tissue weakness, or changes in breast contour

GalaFLEX is one of several surgical mesh products used in soft tissue support techniques.

Other synthetic materials and biologic scaffolds, such as acellular dermal matrices (ADMs), have different compositions, absorption characteristics, indications, and evidence bases.

A procedure described as an “internal bra” does not identify the particular scaffold used; that information is usually found in the operative report or implant records.

Is GalaFLEX FDA-Cleared or Approved for Breast Surgery?

The FDA has cleared certain GalaFLEX products for the repair and reinforcement of soft tissue where weakness exists, but it has not cleared or approved surgical mesh products specifically for breast augmentation or reconstruction.

That distinction appears in the FDA’s November 9, 2023, communication about BD mesh labeling.

The agency stated that the safety and effectiveness of surgical mesh in breast surgery had not been determined by the FDA and advised clinicians to consult the updated product labeling.

BD had updated the relevant labels before the FDA issued its letter, which informed healthcare providers about those updates.

The letter was not a product recall, an enforcement finding, or a determination that GalaFLEX caused a particular injury.

The FDA did not recommend reoperation or mesh removal for patients without symptoms.

The absence of breast-specific clearance does not, by itself, establish that a surgeon’s use of a scaffold was unlawful, that its manufacturer improperly promoted it, or that the device is defective.

Published medical research has separately examined GalaFLEX and other P4HB scaffolds in breast surgery, although clinical research and an FDA determination for a particular use are different things.

P4HB has also been investigated in other soft tissue applications, including hernia repair; findings from those settings should not be treated as proof of outcomes in breast procedures.

What Does Research Say About GalaFLEX in Breast Surgery?

Clinical research on GalaFLEX includes observational studies, retrospective series, tissue analyses, and systematic reviews involving different breast surgery applications.

Many studies describe improved breast support, favorable patient satisfaction, and relatively low complication rates, but the results are not identical across patient groups and procedures.

Multicenter Study of GalaFLEX in Breast Lift and Reduction Procedures

A 2018 multicenter, single-arm clinical study published in Aesthetic Surgery Journal examined GalaFLEX in elective mastopexy and reduction mammoplasty.

Of 69 enrolled patients, 62 received treatment at six U.S. centers; the researchers reported successful correction and maintenance of breast ptosis in 89.7% of treated patients at one year, along with high surgeon and patient satisfaction.

The study reported five device-related adverse events among the 62 treated patients, including nerve pain, swelling, recurrent ptosis, and two cases of asymmetry. The authors nevertheless concluded that the scaffold successfully supported and elevated breast tissue in this study population.

Its authors concluded that GalaFLEX was a useful support material in the procedures studied, although a single-arm study cannot establish how it compares with every alternative technique or predict long-term aesthetic outcomes for every patient.

Systematic Reviews of P4HB Scaffolds

A 2025 systematic review in Aesthetic Surgery Journal examined 16 studies of P4HB in reconstructive and cosmetic breast surgery.

The prospective and retrospective case series in the review generally reported high patient satisfaction and low complication rates, including recurrent ptosis, implant malposition, and capsular contracture. One retrospective cohort study reported a higher capsular contracture rate in a particular two-stage reconstruction technique using a P4HB sling; the other studies did not report a significant increase in capsular contracture.

The review supported P4HB as a useful adjunct in the procedures studied and recommended larger comparative trials. A separate 2024 retrospective study of revision breast reconstruction reported low capsular contracture rates with both biologic and synthetic mesh, with no statistically significant difference between the groups. Because several synthetic products were included, that study cannot be treated as a GalaFLEX-only result.

Another 2025 systematic review specifically examining GalaFLEX in aesthetic breast surgery evaluated seven studies involving 183 patients and found generally favorable breast support and postoperative outcomes.

Because the studies differed substantially and had limited control groups, the authors did not conduct a pooled meta-analysis and cautioned that stronger evidence is needed to determine the best clinical applications.

The studies show both potentially beneficial clinical outcomes and important limits on what can be concluded about other procedures or individual patients.

Research on Tissue Integration and Histologic Characteristics

A 2025 study of GalaFLEX tissue samples examined the histologic characteristics of specimens from ten patients who had undergone later breast surgery.

The researchers observed collagen deposition, blood-vessel development, and gradual changes in the P4HB fibers over time, without evidence of chronic inflammation or a foreign-body response in the sampled tissue.

The authors described a favorable remodeling response. Their conclusions were limited by the ten-patient sample and should not be generalized to every clinical situation.

P4HB is designed as a fully absorbable material, and these tissue findings provide information about remodeling around the scaffold, rather than proving a fixed absorption time or a particular patient’s clinical outcome.

What Complications Can Occur After Breast Surgery?

Breast reconstruction, augmentation, lift, and revision procedures carry recognized postoperative risks, whether or not the surgeon uses mesh or another scaffold. BD also lists possible complications following implantation in its GalaFLEX patient information. These risks should be considered in the context of the procedure and the patient’s medical history.

Possible causes include surgical technique, infection, the condition of the surrounding breast tissue, radiation exposure, implant-related issues, and differences in individual healing.

The fact that a condition developed after implantation does not identify its cause.

Postoperative problems that may require medical evaluation include:

  • Infection affecting the incision, breast pocket, or surrounding tissue
  • Seroma, or a fluid collection that may need aspiration or drainage
  • Hematoma, bleeding, or postoperative swelling
  • Delayed healing, wound separation, or exposure of implanted material
  • Skin necrosis (tissue death) or other tissue damage associated with impaired healing
  • Persistent breast or chest-wall pain, tightness, numbness, or nerve pain
  • Capsular contracture, which can affect breast firmness, comfort, or shape when an implant is present
  • Changes in implant position, asymmetry, contour irregularities, or breast support
  • Implant exposure, implant loss, or reconstruction failure requiring further surgery

The presence of these complications does not, by itself, establish a problem with the scaffold or a basis for legal liability.

Infection, Seroma, and Wound Healing

Infection and fluid collections can occur following breast reconstruction or augmentation with or without mesh support.

Treatment may involve antibiotics, drainage, wound care, or additional surgery depending on severity and the patient’s clinical condition.

Poor circulation, fragile tissue, prior radiation, and other factors may contribute to delayed wound healing or skin necrosis.

When a scaffold is present, clinicians may consider its location and the condition of nearby tissue as part of the overall assessment, but the need for treatment does not establish that the material caused the complication.

Changes in Breast Shape, Implant Position, and Capsular Contracture

A breast implant may change position because of changes in the implant pocket, scar tissue, underlying anatomy, or healing after surgery.

Capsular contracture occurs when scar tissue around an implant tightens and may lead to firmness, discomfort, or distortion.

It is a recognized complication of implant-based breast surgery, not an outcome unique to GalaFLEX or internal bra procedures.

Patients may undergo revision to correct asymmetry, implant malposition, discomfort, or other concerns affecting their result.

Persistent Pain and Revision Surgery

Some people experience ongoing pain, altered sensation, or chest-wall discomfort after breast operations.

Potential contributors include nerve irritation, scar tissue, inflammation, or factors related to the underlying surgery.

Severe wound problems, implant failure, or other reconstructive complications may require implant exchange, removal, or further reconstruction.

The need for corrective surgery documents the patient’s treatment course but does not independently identify the cause of the problem.

GalaFLEX Breast Mesh Lawsuits and Current Litigation Status

TorHoerman Law is reviewing potential individual claims involving breast procedures in which GalaFLEX was implanted. A patient’s medical complication, by itself, does not establish that a product was defective, inadequately labeled, or responsible for that complication.

As of November 16, 2026, our review of publicly available litigation information has not identified a certified nationwide class action or an established federal multidistrict litigation (MDL) specifically for GalaFLEX breast mesh claims. This statement does not describe the status of every individual lawsuit or investigation.

Issues that may be examined in a potential breast mesh claim include:

  • Identification of the exact scaffold and its labeling at the time of surgery
  • The treatment provided and the reason for using additional soft tissue support
  • The patient’s informed-consent documentation and other product-related information
  • The nature and timing of reported postoperative complications
  • Operative findings, clinical opinions, and possible alternative causes of an injury
  • Whether the available evidence supports an alleged product defect, warning claim, or other legal theory

Any allegation concerning product design, warnings, or another legal theory would require reliable evidence specific to the product and patient, as well as a basis under the applicable law. No claim is established merely because an additional procedure or adverse outcome occurred.

Who May Qualify for a GalaFLEX Breast Mesh Claim?

Patients who underwent breast reconstruction, augmentation, reduction, lift, or revision surgery involving GalaFLEX and later needed substantial treatment for a complication may have circumstances worth reviewing.

The extent of the complication, the reason for further treatment, the implanted product, and whether reliable evidence supports a legally recognized claim all affect potential eligibility.

Circumstances that may justify further review include:

  • Infection or persistent fluid collections requiring significant medical treatment
  • Wound breakdown, tissue damage, or skin necrosis requiring surgery or prolonged care
  • Severe or lasting pain supported by medical documentation
  • Significant implant-position changes or reconstructive complications requiring revision
  • Implant removal, mesh-related surgery, or another corrective operation

These circumstances do not automatically qualify a patient for compensation.

Our attorneys consider the medical record and any other evidence relevant to possible causation and liability.

Evidence for an Internal Bra Mesh Claim

A legal review generally begins with confirming which product was used and documenting the medical course after surgery.

Operative reports and implant logs may identify the GalaFLEX product, its catalog or lot number, and its intended placement.

Other personal injury evidence can help establish treatment costs and the effects of a documented injury.

Potential evidence includes:

  • Original surgical records: Operative reports, surgeon notes, implant logs, device stickers, and Unique Device Identifier (UDI) information
  • Follow-up care: Office visits, wound treatment, imaging, cultures, and other records documenting complications
  • Revision records: Notes describing implant exchange, tissue repair, removal of implanted material, or other corrective procedures
  • Pathology and laboratory findings: Available results that may assist in identifying tissue changes or infection
  • Preserved material: Documentation of any explanted scaffold, if a treating facility retains it
  • Financial records: Medical bills, employment records, and documents showing claimed financial losses

Patients should make medical decisions about revision or removal surgery with their treating clinician, not for the purpose of generating evidence for a claim.

If an implant or scaffold is removed during medically indicated care, ask the treating team whether pathology or preservation documentation will be available.

Medical records can establish the sequence of events without necessarily proving that the scaffold caused the injury; additional medical or expert review may be necessary.

Potential Compensation in Breast Mesh Claims

A legally supportable breast mesh claim may involve medical expenses and other damages attributable to an injury for which a defendant is legally responsible.

An adverse postoperative outcome or the use of GalaFLEX does not establish an entitlement to compensation.

Depending on the facts and applicable law, damages may include:

  • Past and future medical costs for necessary treatment or corrective procedures
  • Lost earnings and any demonstrated reduction in earning capacity
  • Physical pain and other ongoing symptoms attributable to the injury
  • Scarring, disfigurement, or lasting functional limitations
  • Emotional distress and loss of enjoyment of life where legally recoverable
  • Other documented out-of-pocket expenses associated with the injury

No GalaFLEX settlement amount or individual claim value can be assumed from the type of procedure or complication alone.

TorHoerman Law: Reviewing GalaFLEX Breast Mesh Claims

At TorHoerman Law, we handle medical device lawsuits and review potential claims involving surgical mesh used in breast procedures.

Our attorneys consider the exact product implanted, the patient’s surgical and treatment history, and any medical evidence relevant to the cause of the reported complications.

An operation that required additional treatment can warrant careful review, but product liability depends on more than a difficult recovery or the need for revision surgery.

If you experienced significant complications after a breast procedure involving GalaFLEX, contact us for a free consultation about whether further legal investigation may be appropriate.

You can also use the chat feature on this page to contact our team.

Frequently Asked Questions

Published by:
Share
Picture of Tor Hoerman
Tor Hoerman

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.

TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.

TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.

Additional Breast Mesh Lawsuit resources on our website:
All
FAQs
Injuries & Conditions
Legal Help
Other Resources
Settlements & Compensation
News

You can learn more about this topic by visiting any of our Breast Mesh Lawsuit pages listed below:

AlloMax Lawsuit
Breast Mesh Lawsuit
Breast Mesh Lawsuit Settlement Amounts: Projections and Estimates
Breast Mesh Lawyer for Internal Bra Complications and Injuries
Internal Bra Complications: Injuries Linked to Defective Breast Mesh
Phasix Breast Mesh Lawsuit
Accepting Clients
Breast Mesh Lawsuit Facts
Defendants
  • Becton, Dickinson and Company (BD)
  • C.R. Bard, Inc.
  • Davol, Inc.
  • Galatea Surgical, Inc.
  • Tepha, Inc.
  • Potentially other manufacturers
Injuries named in lawsuit
  • Serious infections
  • Chronic pain and inflammation
  • Seroma or fluid buildup
  • Wound breakdown or delayed healing
  • Mesh migration or failure to incorporate
  • Tissue necrosis
  • Implant malposition or capsular contracture
  • Cosmetic deformity or breast asymmetry
  • Implant loss or reconstruction failure
  • Need for mesh removal or revision surgery
    You may qualify to file a claim if...
    • You underwent breast reconstruction, augmentation, a breast lift, or revision surgery in which surgical mesh or an “internal bra” product was implanted.
    • You later developed a serious complication such as infection, chronic pain, mesh migration, wound breakdown, tissue necrosis, implant malposition, capsular contracture, or reconstruction failure.
    • Your complications required additional treatment such as revision surgery, mesh or implant removal, implant replacement, hospitalization, or prolonged wound care.
    Have you or a loved one been injured?

    A serious injury can change your life.

    Speak with an experienced personal injury lawyer about your rights, your case, and the legal options available to you.
    Google
    •
    705 reviews
    4.9
    ★★★★★
    Recovered damages
    $4 Billion+

    Table of Contents

    Guides & Resources
    About TorHoerman Law

    TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.

    Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.

    Do you believe you’re entitled to compensation?

    Use our Instant Case Evaluator to find out in as little as 60 seconds!

    $495 Million
    Baby Formula NEC Lawsuit

    In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

    $20 Million
    Toxic Tort Injury

    In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

    $103.8 Million
    COX-2 Inhibitors Injury

    In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

    $4 Million
    Traumatic Brain Injury

    In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

    $2.8 Million
    Defective Heart Device

    In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.

    Other Breast Mesh Lawsuit Resources

    All
    FAQs
    Injuries & Conditions
    Legal Help
    Other Resources
    Settlements & Compensation
    News